About methoxy polyethylene glycol epoetin beta
Long-acting erythropoiesis-stimulating agent
Used for
- Treats anemia caused by chronic kidney disease in adults and children on dialysis.
- Treats anemia caused by chronic kidney disease in some adults not on dialysis.
Usual adult dose
Given by injection every two or four weeks; dose is individualized by hemoglobin, prior treatment, and dialysis status.
Usual dose in children
For children on dialysis aged 5 years and older; given every four weeks, with dose individualized by weight and treatment history.
Common side effects
- High blood pressure
- Diarrhea
- Headache
- Blood clots, including stroke or heart attack
Important warnings
- Can increase risk of death, serious heart problems, stroke, and blood clots, especially with higher hemoglobin levels.
- Use only for anemia due to chronic kidney disease; it is not a substitute for urgent transfusion.
- Blood pressure and hemoglobin require regular monitoring.
- Rarely, severe allergic reactions or pure red cell aplasia can occur.
Pregnancy
Human pregnancy information is limited. Use only when clearly needed; discuss risks and benefits with a clinician.
Breastfeeding
It is unknown whether this medicine passes into breast milk. Consider treatment needs and infant feeding with a clinician.
Interactions
- No major specific drug interactions are established; blood pressure medicines may need adjustment as anemia improves.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.